Current Allergy and Asthma Reports

, Volume 2, Issue 6, pp 488–493 | Cite as

Aspirin intolerance and nasal polyposis

  • César Picado


Chronic rhinosinusitis with nasal polyposis usually develops in aspirin-sensitive patients with asthma. Arachidonic acid metabolism appears to be abnormal in the nasal polyps of aspirin-sensitive patients with asthma. These abnormalities are characterized by a low production of prostaglandin E2 (PGE2) and a high release of cysteinyl leukotrienes. Moreover, cyclooxygenase-2 is markedly downregulated in polyps from aspirin-sensitive patients with asthma. This abnormality may explain the low production of PGE2 in nasal polyps and may account for the increased susceptibility to the inhibitory effects of aspirin. Nasal instillation or ingestion of aspirin induces a nasal reaction in most aspirinsensitive patients with asthma. This reaction is accompanied by the influx of eosinophils and a concomitant increase in cysteinyl leukotrienes, tryptase, and eosinophil cationic protein release. The aspirin nasal challenge is a very safe test with a moderate sensibility and high specificity that can be used in the diagnosis of aspirin intolerance. The similarities in the reaction between the nose and airways in aspirin-sensitive patients provide compelling evidence for common pathogenic mechanisms for nasal polyps, chronic rhinosinusitis, and bronchial asthma.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Widal MF, Abram P, Lermoyez J: Anaphylaxie et idiosyncraise. Press Med 1922, 119:48–51.Google Scholar
  2. 2.
    Samter M, Beers RF: Intolerance to aspirin: clinical studies and consideration of its pathogenesis. Ann Intern Med 1968, 68:875–883.Google Scholar
  3. 3.
    Spector SL, Wangaard CH, Farr RS: Aspirin and concomitant in adult asthmatic patients. J Allergy Clin Immunol 1979, 64:500–506.PubMedCrossRefGoogle Scholar
  4. 4.
    Settipane GA: Nasal polyps: epidemiology, pathology, immunology, and treatment. Am J Rhinol 1987, 1:119–126.Google Scholar
  5. 5.
    Schiavino D, Nucera E, Milani A, et al.: The aspirin disease. Thorax 2000, 55(suppl 2):S66-S69.PubMedCrossRefGoogle Scholar
  6. 6.
    Kowalski M: Rhinosinusitis and nasal polyposis in aspirin sensitive and aspirin tolerant patients: are they different? Thorax 2000, 55(suppl 2):S84-S86.PubMedCrossRefGoogle Scholar
  7. 7.
    Chafee FH, Settipane GA: Aspirin intolerance: I. Frequency in an allergic population. J Allergy Clin Immunol 1974, 53:193–199.CrossRefGoogle Scholar
  8. 8.
    Szceklik A, Nizankowska E, Duplaga M: Natural history of aspirin-induced asthma. Eur Respir J 2000, 16:432–436. Description of the natural history of aspirin-sensitive asthma in a sample of 500 patients.CrossRefGoogle Scholar
  9. 9.
    Varga EM, Jacobson MR, Masuyama K, et al.: Inflammatory cell populations and cytokine mRNA expression in the nasal mucosa in aspirin-sensitive rhinitis. Eur Respir J 1999, 14:610–615.PubMedCrossRefGoogle Scholar
  10. 10.
    Jordana M, Dolovich J, Ohno I, et al.: Nasal polyposis: a model for chronic inflammation. In Asthma and Rhinitis. Edited by Holgate ST, Busse WW. Boston, MA: Blackwell Scientific; 1995:156–164.Google Scholar
  11. 11.
    Wong GG, Jordana M, Denburg J, Dolovich J: Blood eosinophilia and nasal polyps. Am J Rhinol 1992, 6:195–198.Google Scholar
  12. 12.
    Terries MH, Davidson TM: Review of published results for endoscopic sinus surgery. Ear Nose Throat J 1994, 73:574–580.Google Scholar
  13. 13.
    Stevenson DD: Diagnosis, prevention and treatment of adverse reactions to aspirin and nonsteroidal anti-inflammatory drugs. J Allergy Clin Immunol 1984, 74:617–622.PubMedCrossRefGoogle Scholar
  14. 14.
    Castillo JA, Picado C: Prevalence of aspirin-intolerance in a hospital population. Respiration 1986, 50:153–157.PubMedCrossRefGoogle Scholar
  15. 15.
    Dahlén B, Zetterström O: Comparison of bronchial and per oral provocation with aspirin in aspirin-sensitive asthmatics. Eur Respir J 1990, 3:527–534.PubMedGoogle Scholar
  16. 16.
    Nizankowska E, Bestynska-Krypel A, Cmiel A, Szczeklik A: Oral and bronchial provocation tests with aspirin for the diagnosis of aspirin-induced asthma. Eur Respir J 2000, 15:863–869.PubMedCrossRefGoogle Scholar
  17. 17.
    Patriarca G, Nucera E, DiRienzo V, et al.: Nasal provocation test with lysine acetylsalicylate in aspirin-sensitive patients. Ann Allergy 1991, 67:60–62.PubMedGoogle Scholar
  18. 18.
    Milewski M, Mastalerz L, Nizankowska E, Szczeklik A: Nasal provocation test with lysine-aspirin for diagnosis of aspirinsensitive asthmatics. J Allergy Clin Immunol 1998, 101:581–586. Shows that aspirin nasal challenge can be used in the study of aspirin sensitivity assessed by rhinomanometry.PubMedCrossRefGoogle Scholar
  19. 19.
    Casadevall J, Mullol J, Picado C: Intranasal challenge with aspirin in the diagnosis of aspirin sensitive asthma. Evaluation of nasal response by acoustic rhinometry. Thorax 2000, 55:921–924. Study on the usefulness and tolerability of aspirin nasal challenge in the study of aspirin sensitivity assessed by acoustic rhinometry.PubMedCrossRefGoogle Scholar
  20. 20.
    Szczeklik A, Gryglewski RJ, Olszewski E, et al.: Aspirin-sensitive asthma: the effect of aspirin on the release of prostaglandins from nasal polyps. Pharmacol Res Commun 1977, 9:415–425.PubMedCrossRefGoogle Scholar
  21. 21.
    Kowalski ML, Pawliczak R, Wozniak J, et al.: Differential metabolism of arachidonic acid in nasal polyp epithelial cells cultured from aspirin-sensitive and aspirin-tolerant patients. Am J Respir Crit Care Med 2000, 161:391–398. An abnormal regulation of PGE2 is reported in cultured epithelial cells of nasal polyps obtained from aspirin-sensitive subjects.PubMedGoogle Scholar
  22. 22.
    Schmid M, Gode U, Schafer D, Wigand ME: Arachidonic acid metabolism in nasal tissue and peripheral blood cells in aspirin intolerant asthmatics. Acta Otolaryngol (Stockh) 1999, 119:277–280.CrossRefGoogle Scholar
  23. 23.
    Picado C, Fernandez-Morata F, Juan M, et al.: Cycloxygenase-2 mRNA is downexpressed in nasal polyps from aspirin-sensitive asthmatics. Am J Respir Crit Care Med 1999, 160:291–296. COX-2 is downregulated in polyps from aspirin-sensitive asthmatics. This abnormality might explain the low production of PGE2 in nasal polyps and might also account for the increased susceptibility to the inhibitory effects of aspirin.PubMedGoogle Scholar
  24. 24.
    Ferreri NR, Howland WC, Stevenson DD, Spiegelberg HL: Release of leukotrienes, prostaglandins and histamine into nasal secretion of aspirin-sensitive asthmatics during reaction to aspirin. Am Rev Respir Dis 1988, 137:847–854.PubMedGoogle Scholar
  25. 25.
    Picado C, Ramis I, Rosellò J, et al.: Release of peptide leukotriene into nasal secretions after local instillation of aspirin in aspirin-sensitive asthmatic patients. Am Rev Respir Dis 1992, 145:65–69.PubMedGoogle Scholar
  26. 26.
    Christie PE, Tagari P, Ford-Hutchinson AW, et al.: Urinary leukotriene E4 concentrations increase after ASA challenge in ASA-sensitive subjects. Am Rev Respir Dis 1991, 143:1025–1029.PubMedGoogle Scholar
  27. 27.
    Kumlin M, Dahlén B, Björck T, et al.: Urinary excretion of leukotriene E4 and 11-dehydro-tromboxane B2 in response to bronchial provocations with allergen, aspirin, leukotriene D4 and histamine in asthmatics. Am Rev Respir Dis 1992, 146:96–103.PubMedGoogle Scholar
  28. 28.
    Szczeklik A, Sladek K, Dworski R, et al.: Bronchial aspirin challenge causes specific eicosanoid response in aspirin-sensitive asthmatics. Am J Respir Crit Care Med 1996, 154:1608–1614.PubMedGoogle Scholar
  29. 29.
    Sladek K, Dworski J, Soja J, et al.: Eicosanoids in bronchoalveolar lavage fluid of aspirin-intolerant patients with asthma after aspirin challenge. Am J Respir Crit Care Med 1994, 149:940–946.PubMedGoogle Scholar
  30. 30.
    Kowalski ML, Grzegorczyk J, Wojciechowska B, Poniatowska M: Intranasal challenge with aspirin induces cell influx and activation of eosinophils and mast cells in nasal secretions of ASA-sensitive patients. Clin Exp Allergy 1996, 26:807–814.PubMedCrossRefGoogle Scholar
  31. 31.
    Fischer AR, Rosenberg MA, Lilly CM, et al.: Direct evidence for a role of mast cell in the nasal response to aspirin in aspirinsensitive patients. J Allergy Clin Immunol 1994, 94:1046–1056.PubMedCrossRefGoogle Scholar

Copyright information

© Current Science Inc. 2002

Authors and Affiliations

  • César Picado
    • 1
  1. 1.Servei de Pneumologia, Hospital ClinicBarcelonaSpain

Personalised recommendations